Try our Advanced Search for more refined results

Expert Analysis

What Attorneys Should Know About FDA's MedWatch Data

Law360, New York (January 29, 2014, 5:11 PM EST) -- Following the introduction of new pharmaceuticals, reports of adverse events often surface in the news media. Some drugs, particularly blockbusters, eventually become the subject of lawsuits. Attorneys involved in these cases need to be fully informed about the quality and limitations of the spontaneous adverse event data used by the U.S. Food & Drug Administration, pharmacovigilance researchers and activist groups in monitoring post-marketing drug safety. Ignoring the limitations of this data may result in erroneous inference about the causal relationship between drug use and reported adverse events....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!